Device type · LKJ
Antinuclear Antibody, Antigen, Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LKJ
Immunology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Antinuclear Antibody, Antigen, Control
- Product code
- LKJ
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LKJ
Latest FDA decisions
- EliA Ro52, EliA Ro60510(k)
K210902 · Decided Jul 27, 2022 · 488 days after receipt
Device type: Antinuclear Antibody, Antigen, Control (LKJ) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0082-2022 · Started Nov 1, 2019
Reason given: A new lot of ANA screen control and any subsequent control lots are incompatible with older lot numbers of ANA calibrators and ANA reagent packs.
Cause as FDA categorized it: Process control
Z-2627-2017 · Started May 22, 2017
Reason given: FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the...
Cause as FDA categorized it: Other
Z-0306-2018 · Started Feb 14, 2017 · Posted by FDA Dec 20, 2017
Reason given: Euro Diagnostica has identified a deviation in one of the components of the DIASTAT ANA (FANA200), lot TS 2076. The kit might not perform correctly and so potentially yield false positive samples.
Cause as FDA categorized it: Nonconforming Material/Component
10 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.